
zzso and obesity are zzso as responsible for an increase in vascular risk and in excess mortality due to zzso zzso This is especially true in presence of increased visceral zzso fat distribution, a key factor for zzso the main component of the zzso syndrome zzso zzso risk in overweight and obese subjects appears strongly correlated with the common risk factors, more frequently present in these zzso type 2 diabetes, hypertension, zzso zzso Weight reduction improves all risk factors and decreases the patient's global vascular zzso The improvement in the various risk factors is significant with a moderate weight loss zzso of the initial zzso Weight reduction should been obtained always with zzso means (physical activity, zzso zzso maintained for several zzso Only when these approaches appear to be insufficient, the need for an associated pharmacological treatment has to be zzso zzso the zzso drugs currently available or close to be, zzso has demonstrated its interest in the zzso control of type 2 diabetic patients, and its zzso effect in zzso zzso Available clinical studies have clearly shown the more marked effect of zzso in comparison to zzso in reducing the various risk zzso So far, few studies have been conducted to assess the effects of the specific drug therapy on the control of zzso abnormalities and risk factors in overweight or obese patients, except in type 2 diabetic patients for whom, most of the oral zzso agents have been tested in overweight or obese diabetic zzso 

